Literature DB >> 35781841

The role of comorbid depressive symptoms on long-range temporal correlations in resting EEG in adults with ADHD.

Matti Gärtner1,2, Maria Strauß3, Jue Huang4, Eike Ahlers1, Holger Bogatsch5, Pierre Böhme6, Thomas Ethofer7,8, Andreas J Fallgatter8, Jürgen Gallinat9, Ulrich Hegerl10, Isabella Heuser1, Knut Hoffmann6, Sarah Kittel-Schneider10,11, Andreas Reif10, Daniel Schöttle9, Stefan Unterecker11.   

Abstract

Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder, characterized by core symptoms of inattention, hyperactivity and impulsivity. Comorbid depression is commonly observed in ADHD-patients. Psychostimulants are recommended as first-line treatment for ADHD. Aberrant long-range temporal correlations (LRTCs) of neuronal activities in resting-state are known to be associated with disorganized thinking and concentrating difficulties (typical in ADHD) and with maladaptive thinking (typical in depression). It has yet to be examined whether (1) LRTC occur in ADHD-patients, and if so, (2) whether LRTC might be a competent biomarker in ADHD comorbid with current depression and (3) how depression affects psychostimulant therapy of ADHD symptoms. The present study registered and compared LRTCs in different EEG frequency bands in 85 adults with ADHD between groups with (n = 28) and without (n = 57) additional depressive symptoms at baseline. Treatment-related changes in ADHD, depressive symptoms and LRTC were investigated in the whole population and within each group. Our results revealed significant LRTCs existed in all investigated frequency bands. There were, however, no significant LRTC-differences between ADHD-patients with and without depressive symptoms at baseline and no LRTC-changes following treatment. However, depressed ADHD patients did seem to benefit more from the therapy with psychostimulant based on self-report.
© 2022. The Author(s).

Entities:  

Keywords:  ADHD; Depression; EEG; LRTC; Long-range temporal correlation; Resting state

Year:  2022        PMID: 35781841     DOI: 10.1007/s00406-022-01452-2

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  49 in total

Review 1.  Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).

Authors:  Esther Sobanski
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09       Impact factor: 5.270

2.  Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients.

Authors:  Anne Halmøy; Ole Bernt Fasmer; Christopher Gillberg; Jan Haavik
Journal:  J Atten Disord       Date:  2009-04-16       Impact factor: 3.256

3.  Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center.

Authors:  Christian P Jacob; Jasmin Romanos; Astrid Dempfle; Monika Heine; Christine Windemuth-Kieselbach; Anja Kruse; Andreas Reif; Susanne Walitza; Marcel Romanos; Alexander Strobel; Burkhard Brocke; Helmut Schäfer; Armin Schmidtke; Jobst Böning; Klaus-Peter Lesch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-04-01       Impact factor: 5.270

Review 4.  Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines.

Authors:  Josep Antoni Ramos-Quiroga; Alonso Montoya; Alexandra Kutzelnigg; Walter Deberdt; Esther Sobanski
Journal:  Curr Med Res Opin       Date:  2013-07-02       Impact factor: 2.580

5.  The role of comorbid major depressive disorder in the clinical presentation of adult ADHD.

Authors:  Aline G Fischer; Claiton H D Bau; Eugenio H Grevet; Carlos A I Salgado; Marcelo M Victor; Katiane L S Kalil; Nyvia O Sousa; Christiane R Garcia; Paulo Belmonte-de-Abreu
Journal:  J Psychiatr Res       Date:  2006-11-13       Impact factor: 4.791

6.  The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Lenard Adler; Russell Barkley; Joseph Biederman; C Keith Conners; Olga Demler; Stephen V Faraone; Laurence L Greenhill; Mary J Howes; Kristina Secnik; Thomas Spencer; T Bedirhan Ustun; Ellen E Walters; Alan M Zaslavsky
Journal:  Am J Psychiatry       Date:  2006-04       Impact factor: 18.112

7.  Adult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up study.

Authors:  Joseph Biederman; Carter R Petty; K Yvonne Woodworth; Alexandra Lomedico; Laran L Hyder; Stephen V Faraone
Journal:  J Clin Psychiatry       Date:  2012-07       Impact factor: 4.384

Review 8.  Attention-deficit/hyperactivity disorder.

Authors:  Stephen V Faraone; Philip Asherson; Tobias Banaschewski; Joseph Biederman; Jan K Buitelaar; Josep Antoni Ramos-Quiroga; Luis Augusto Rohde; Edmund J S Sonuga-Barke; Rosemary Tannock; Barbara Franke
Journal:  Nat Rev Dis Primers       Date:  2015-08-06       Impact factor: 52.329

9.  Demographic Differences in Disruptive Mood Dysregulation Disorder Symptoms in ADHD, Autism, and General Population Samples.

Authors:  Susan D Mayes; Susan L Calhoun; James G Waxmonsky; Cari Kokotovich; Raman Baweja; Robin Lockridge; Edward O Bixler
Journal:  J Atten Disord       Date:  2016-08-22       Impact factor: 3.256

Review 10.  Adult ADHD and comorbid disorders: clinical implications of a dimensional approach.

Authors:  Martin A Katzman; Timothy S Bilkey; Pratap R Chokka; Angelo Fallu; Larry J Klassen
Journal:  BMC Psychiatry       Date:  2017-08-22       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.